City Hill Ventures
Contact Us  
Home About Us Team News

News and Events

Ignyta Receives Orphan Drug Designation from FDA for Entrectinib for the Treatment of Molecularly Defined Subsets of Colorectal Cancer

2.17.15 press release

© 2010 City Hill Ventures, LLC Home    About Us    Team    Portfolio    News    Contact Us
Learn More